ReviewMolecules (Basel, Switzerland)2026
Research on the Current Development Status of Redox Flow Batteries.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanoflower-like CuCoMaterials (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
In recent years, flow batteries have emerged as a crucial technological solution for large-scale energy storage, leveraging their unique power-capacity decoupling characteristics and long cycle life to demonstrate significant potential in applications such as renewable energy integration and grid frequency regulation. Based on differences in electrolyte systems, mainstream flow battery technologies are primarily categorized into three types: all-vanadium redox flow batteries (VRFBs), iron-chromium redox flow batteries (ICFBs), and zinc-based redox flow batteries (ZRFBs). However, each of these technologies faces critical challenges in practical commercialization: VRFBs are constrained by cost pressures due to fluctuations in vanadium resource prices and relatively low energy efficiency; ICFBs require urgent solutions to issues such as hydrogen evolution side reactions at the negative electrode and the sluggish kinetic responses of the Cr
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.